$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Detailed instructions on the usage and dosage of Tarlatamab-Imdelltra and the clinical medication regimens for different patients.
2026-02-01 22:25:32
Check Details
Telisotuzumab-EMRELIS applicable cancer types and clinical treatment options for different patients
2026-02-01 22:25:32
Check Details
A comprehensive explanation of which cancers tovorafenib is used to treat and its clinical efficacy and indications
2026-02-01 22:25:32
Check Details
Detailed description of vorasidenib-VORANIGO manufacturer and drug background, R&D companies and qualification information
2026-02-01 22:25:32
Check Details
Where can I buy Zongatinib (Zongatinib) in China and the explanation of the formal channels for purchasing the drug?
2026-02-01 22:25:32
Check Details
Analysis of clinical effects of vosoritide, observation of efficacy in different patients, and summary of medication experience
2026-02-01 22:25:32
Check Details
Is Methylcobalamin Injection (Rozebalamin) Effective for Patients with Anxiety Disorders and Its Psychological Improvement Mechanism
2026-02-01 22:25:32
Check Details
Analysis of the latest price and reimbursement ratio of cobimetinib in 2025 after it enters medical insurance
2026-02-01 22:25:32
Check Details
The best domestic macitentan tablets brand and market price analysis report
2026-02-01 22:25:32
Check Details
Differences and analysis of combined use of Pitolisant and venlafaxine in the treatment of drowsiness
2026-02-01 22:25:32
Check Details
Differences between commonly used anti-tuberculosis drugs Pretomanid and rifampin and analysis of combination treatment strategies
2026-02-01 22:25:32
Check Details
Top 10 contraindications for Elotuzumab
2026-02-01 22:25:32
Check Details
1
2
...
2414
2415
2416
2417
2418
2419
2420
...
10214
10215
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
LONSURF® (Trifluridine/Tipiracil): Unveiling the Global R&D and Supply Chain Behind the Oral Chemotherapy
2
Breaking the Bottleneck: KOSELUGO® (Selumetinib) Reshapes the Treatment Landscape for Neurofibromatosis Type 1 (NF1)
3
FDA Approves Lilly's Inluriyo (Imlunestrant) for ESR1-Mutant Advanced Breast Cancer
4
Niraparib: A PARP Inhibitor for Ovarian Cancer Maintenance Therapy
5
Abiraterone Acetate: CYP17 Inhibitor for Advanced Prostate Cancer
6
Plerixafor: Mobilizing Hematopoietic Stem Cells for Autologous Transplantation
7
Brensoctib: Managing Side Effects of the Novel DPP-1 Inhibitor for Bronchiectasis
8
Tivozanib: The Evolution of Highly Selective VEGFR Inhibition in Renal Cell Carcinoma
9
Trifluridine/Tipiracil: Managing Side Effects in Metastatic Colorectal and Gastric Cancer
10
Trelagliptin: The First Once-Weekly DPP-4 Inhibitor Revolutionizing Type 2 Diabetes Care
11
Adagrasib Medication Management Guide for Special Populations
12
Olutasidenib (Rezlidhia): A Targeted Drug for IDH1-Mutated Relapsed/Refractory AML